After cancer and heart disease, neurodegenerative diseases, such as Alzheimer's, Parkinson's, multiple sclerosis (MS), amythrophic lateral sclerosis (ALS), take more lives each year than any other illness. Although great progress has been made in recent years toward understanding of neurodegenerative diseases, few effective treatments and no cures are currently available. This is mainly because the blood-brain barrier (BBB) limits the delivery of the vast majority of systemically-administered drugs available to treat those diseases. The underlying hypothesis of this study is that delivery of therapeutic molecules is safe and effective through the blood-brain barrier (BBB) using Focused Ultrasound (FUS). Our preliminary results have shown that the FUS technique can induce BBB opening entirely noninvasively, selectively and be monitored with MRI at sub-millimeter resolution in vivo, both in normal mice and Alzheimer's-model mice. The primary objective of this study is thus to establish the neurotherapeutic potential of trans-BBB delivery using FUS, i.e., determine its complete safety and efficacy profiles. Once those are established, a secondary objective entails the potential for translation to the clinic, i.e., development of FUS prototypes for non-human primate and human use for future large animal and clinical assessment, respectively. The multi-disciplinary team assembled encompasses all critical specialty areas such as ultrasound engineering, Alzheimer's pathophysiology in animals and humans, histological and behavioral studies and transgenic model development as well as MR and fluorescence imaging expertise.
The specific aims of the study are therefore to: 1) assess the safety of the BBB opening in the presence or absence of disease in vivo;2) evaluate the efficacy of FUS-enhanced pharmacological therapies in vivo;and 3) build and test the FUS systems for transcranial BBB opening in non- human primates and humans. Following the proposed studies, this entirely noninvasive and highly localized BBB opening method will be tested in large animals and, ultimately, humans in conjunction with the most promising, systemically administered pharmacological agents to demonstrate its true clinical potential, for Alzheimer's or other neurodegenerative or neurological diseases.

Public Health Relevance

Due to the impermeability of the blood-brain barrier (BBB), neurological disorders and all age-related neurodegenerative diseases remain undertreated despite the thousands of pharmacological agents available. The primary objective of this study is thus to establish the neurotherapeutic potential of trans-BBB delivery using FUS. A secondary objective entails assessment of its potential for translation to clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG038961-03
Application #
8484327
Study Section
Medical Imaging Study Section (MEDI)
Program Officer
Petanceska, Suzana
Project Start
2011-08-01
Project End
2016-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
3
Fiscal Year
2013
Total Cost
$305,973
Indirect Cost
$112,248
Name
Columbia University (N.Y.)
Department
Biomedical Engineering
Type
Schools of Engineering
DUNS #
049179401
City
New York
State
NY
Country
United States
Zip Code
10027
Wang, Shutao; Karakatsani, Maria E; Fung, Christine et al. (2016) Direct brain infusion can be enhanced with focused ultrasound and microbubbles. J Cereb Blood Flow Metab :
Chen, Hong; Yang, Georgiana Zong Xin; Getachew, Hoheteberhan et al. (2016) Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Sci Rep 6:28599
Kamimura, Hermes A S; Wang, Shutao; Chen, Hong et al. (2016) Focused ultrasound neuromodulation of cortical and subcortical brain structures using 1.9 MHz. Med Phys 43:5730
Kamimura, H A S; Wang, S; Wu, S-Y et al. (2015) Chirp- and random-based coded ultrasonic excitation for localized blood-brain barrier opening. Phys Med Biol 60:7695-712
Wu, Shih-Ying; Chen, Cherry C; Tung, Yao-Sheng et al. (2015) Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain. J Control Release 212:30-40
Sun, Tao; Samiotaki, Gesthimani; Wang, Shutao et al. (2015) Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening. Phys Med Biol 60:9079-94
Downs, Matthew E; Buch, Amanda; Sierra, Carlos et al. (2015) Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task. PLoS One 10:e0125911
Downs, Matthew E; Buch, Amanda; Karakatsani, Maria Eleni et al. (2015) Blood-Brain Barrier Opening in Behaving Non-Human Primates via Focused Ultrasound with Systemically Administered Microbubbles. Sci Rep 5:15076
Samiotaki, Gesthimani; Acosta, Camilo; Wang, Shutao et al. (2015) Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo. J Cereb Blood Flow Metab 35:611-22
Wang, S; Olumolade, O O; Sun, T et al. (2015) Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus. Gene Ther 22:104-10

Showing the most recent 10 out of 19 publications